Comparing magnetic field therapy and electrical stimulation for knee osteoarthritis
Magnetic Field Therapy Versus Transcutaneous Electrical Nerve-stimulation in Knee Osteoarthritis: a Head-to-head Trial
NA · University Tunis El Manar · NCT06406231
This study is testing whether a new magnetic field therapy can help people with knee osteoarthritis feel better and move easier compared to a common electrical stimulation treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Sex | All |
| Sponsor | University Tunis El Manar (other) |
| Locations | 1 site (Tunis) |
| Trial ID | NCT06406231 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of Pulsed Electromagnetic Field (PEMF) therapy in improving physical function and alleviating pain in patients with knee osteoarthritis (OA). It aims to compare the efficacy of PEMF therapy against Transcutaneous Electrical Nerve Stimulation (TENS) in managing symptoms associated with knee OA. The study includes patients diagnosed with knee OA who meet specific criteria, focusing on their physical function and pain levels. The outcomes will help determine if PEMF can be a viable treatment option for knee OA.
Who should consider this trial
Good fit: Ideal candidates are individuals over 50 years old with knee pain due to osteoarthritis who meet specific diagnostic criteria.
Not a fit: Patients with contraindications such as pacemakers, active infections, or those who have undergone total knee replacement may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new non-invasive treatment option for patients suffering from knee osteoarthritis.
How similar studies have performed: While the effectiveness of PEMF therapy remains debated, this study aims to provide new insights, as similar approaches have shown mixed results in the past.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * We included patients who had knee pain due to knee OA diagnosed according to the American College of Rheumatology including: * Knee pain AND presence of at least three of the following 6 criteria: * Age \> 50 years * Morning stiffness \< 30 minutes * Crepitus during movement * Periarticular bone pain * Periarticular bone hypertrophy * Absence of increased local warmth. Exclusion Criteria: * For both groups, we did not include: * Patients with a pacemaker, implantable defibrillator, cochlear implant, or any metal implant contraindicating MRI (knee prosthesis, hip prosthesis, etc.). * Pregnant women * Patients with an active infection * Profound hypoesthesia or thermoalgic sensitivity disorder * Poorly vascularized areas: arteritis, phlebitis, ischemia * Patients on anti-vitamin K treatment or with a coagulation disorder. Patients with long-term corticosteroid therapy or having a total knee replacement, those who have received therapies for knee osteoarthritis including intra-articular corticosteroid injection or viscosupplementation in the last 4 months, and Patients with knee pain of non-osteoarthritic origin were also not included in the study.
Where this trial is running
Tunis
- Military Hospital of Tunis — Tunis, Tunisia (RECRUITING)
Study contacts
- Study coordinator: Emna RAZGALLAH, medical resident
- Email: emna.razgallah123@gmail.com
- Phone: 25484674
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Knee Osteoarthritis